VIE/LUNB (VIE/LUNB)

Vienna Stock Exchange: VIE/LUNB · EUR

€7.28

+0.21 (+3.0%)· Recorded snapshot

Market cap	7.1B
Revenue (ttm)	3.5B
Net income (ttm)	526.3M
EPS (ttm)	€0.53
P/E (trailing)	13.7x
P/E (forward)	8.4x
Dividend	€0.15 (2.12%)
Volume	6

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.5B
Net income (ttm): 526.3M
EPS (ttm): €0.53
P/E (trailing): 13.7x
P/E (forward): 8.4x
Market cap: 7.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E8.4

P25 n/aP50 n/aP75 n/a

Trailing P/E13.7

P25 n/aP50 n/aP75 n/a

ROE15.4

P25 n/aP50 n/aP75 n/a

ROIC13.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/LUNB indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

DKK

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	AT
Earnings date	2026-11-11
Employees	5,000
Employees change	-700
Employees growth	-12.28%
Enterprise value	EUR 8.1B
Exchange	Vienna Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-07-19
Fiscal year end	December
Founded	1915
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	DK0061804770
Last earnings date	2026-08-19
Last refreshed	2026-10-29
Market cap	EUR 7.1B
Next earnings date	2026-11-11
Price	EUR 7.28
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	vie/LUNB
Website	https://www.lundbeck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	12.51x
Average P/E ratio (5Y)	13.63x
Earnings yield	7.3%
EV/Earnings	14.93x
EV/EBIT	9.05x
EV/EBITDA	7.02x
EV/FCF	11.25x
EV/Sales	2.26x
FCF / EV yield	8.89%
FCF yield	10.13%
Forward P/E	8.38x
Graham number	6.68846
Graham upside	-5.33%
Lynch fair value	EUR 8.04
Lynch upside	13.8%
P/B ratio	1.92x
P/E ratio	13.71x
P/FCF ratio	9.87x
P/OCF ratio	8.89x
P/S ratio	1.98x
Price/EBITDA ratio	6.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.99%
EBITDA margin	31.86%
Effective tax rate	27.65%
FCF margin	20.1%
Gross margin	82.06%
Operating margin	24.99%
Pretax margin	20.95%
Profit margin	15.16%
Profit per employee	EUR 105,266
Profitable quarters	2
Profitable years	10
Revenue per employee	EUR 694,460
ROA	7.76%
ROA (5Y)	5.44%
ROCE	14.97%
ROE	15.41%
ROE (5Y)	10.83%
ROIC	13.67%
ROIC (5Y)	11.12%
Tax / revenue	5.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	14.67%
EPS growth (Q)	22.11%
EPS growth (QoQ)	-30.54%
EPS growth 3Y	16.68%
EPS growth 5Y	14.93%
EPS growth quarters	2
EPS growth years	4
FCF growth	79.51%
FCF growth (Q)	22.04%
FCF growth (QoQ)	279.5%
FCF growth 3Y	9.54%
FCF growth 5Y	15.93%
Gross profit growth	11.06%
Gross profit growth (Q)	5.35%
Gross profit growth 3Y	12.21%
Gross profit growth 5Y	10.5%
Net income growth	14.72%
Net income growth (Q)	21.74%
Net income growth (QoQ)	-30.76%
Net income growth 3Y	16.65%
Net income growth 5Y	14.9%
Net income growth quarters	2
Net income growth years	4
OCF growth	70.05%
OCF growth (Q)	21.42%
OCF growth (QoQ)	230.22%
OCF growth 10Y	7.72%
OCF growth 3Y	9.16%
OCF growth 5Y	14.76%
Operating income growth	25.88%
Operating income growth (Q)	-2.79%
Operating income growth 3Y	22.95%
Operating income growth 5Y	20.12%
Revenue growth	10.37%
Revenue growth (Q)	7.31%
Revenue growth (QoQ)	-9.29%
Revenue growth 10Y	5.69%
Revenue growth 3Y	10.23%
Revenue growth 5Y	8.87%
Revenue growth quarters	18
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -77.2M
Depreciation and amortization	EUR 238.4M
EBIT	EUR 867.8M
EBITDA	EUR 1.1B
EPS	EUR 0.53
Financing cash flow	EUR -753M
Free cash flow	EUR 698.2M
Gross profit	EUR 2.8B
Income taxes	EUR 201.2M
Investing cash flow	EUR -84.8M
Net borrowing	EUR -581M
Net cash flow	EUR -60.3M
Net income	EUR 526.3M
Operating income	EUR 867.8M
Revenue	EUR 3.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.6
Book value per share	EUR 3.63
Debt / EBITDA	1.13
Debt / equity	0.35
Debt / FCF	1.8
Interest coverage	405.5
Long-term assets	EUR 5.3B
Long-term liabilities	EUR 2.2B
Net cash (debt)	EUR -965.8M
Net cash / market cap	-14.02%
Net debt / EBITDA	0.87
Net debt / equity	0.27
Net debt / FCF	1.38
Piotroski F-Score	6
Property, plant and equipment	EUR 404.6M
Shareholders' equity	EUR 3.6B
Tangible book value	EUR -1.2B
Tangible book value per share	EUR -1.24
Total assets	EUR 7B
Total cash	EUR 293.7M
Total debt	EUR 1.3B
Total liabilities	EUR 3.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	EUR 1.7B
Current liabilities	EUR 1.3B
Current ratio	1.37
Inventory turnover	1.12
Net working capital	EUR 175.2M
Quick ratio	0.9
Working capital	EUR 459.5M
Working capital turnover	0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.04%
Dividend growth	20.79%
Dividend growth years	2
Dividend payment date	2026-03-23
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	EUR 0.15
Dividend yield	2.12%
Ex-dividend date	2026-03-19
Last dividend	EUR 0.15
Payout ratio	29%
Shareholder yield	2.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 5.78
1D price change	2.97%
1M price change	17.26%
1M total return	17.26%
1W price change	6.32%
1W total return	6.32%
1Y price change	13.86%
1Y return CAGR	17.42%
1Y total return	17.41%
20-day SMA	EUR 6.42
200-day SMA	EUR 5.67
3M price change	24.17%
3M total return	24.17%
3Y price change	44.83%
3Y return CAGR	16.08%
3Y total return	56.44%
50-day SMA	EUR 6.04
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 7.28
52-week high date	2026-10-29
52-week low	EUR 4.85
52-week low date	2026-02-05
6M price change	22.55%
6M total return	22.55%
All-time high	EUR 8.85
All-time high date	2022-08-04
All-time low	EUR 3.26
All-time low date	2022-10-06
Average true range (ATR)	EUR 0.13
Average volume	5.7
Change from 52-week high	0%
Change from 52-week low	49.94%
Change from all-time high	-20.13%
Change from all-time low	116.78%
Change from open	2.75%
Day's gap	0.21%
Dollar volume	EUR 43.65
High price	EUR 7.28
Low price	EUR 7.08
Monthly RSI	67.94
Open price	EUR 7.08
Position in 52-week range	100%
Previous close	EUR 7.07
Price vs 150-day SMA	22.15%
Price vs 20-day SMA	10.1%
Price vs 200-day SMA	24.63%
Price vs 50-day SMA	17.07%
Relative volume	0.98
RSI	84.26
Sharpe ratio	0.59
Sharpe ratio (3Y)	0.54
Sortino ratio	0.97
Sortino ratio (3Y)	0.99
Volume	6
Weekly RSI	72.69
YTD price change	22.34%
YTD total return	26.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	304.9M
Shares change (QoQ)	-0.28%
Shares change (YoY)	0.04%
Shares held by insiders	0.13%
Shares held by institutions	10.95%

Deeper analysis on VIE/LUNB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/LUNB report

Is a complete VIE/LUNB research report available?

No complete published report is available for vie/LUNB (VIE/LUNB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/LUNB (VIE/LUNB)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/LUNB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/LUNB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/LUNB

Frequently asked questions